ANDREW MILONE: Open Payments
NPI 1366450892 · BOONVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 35 payments from 14 companies in 2025. Trend: 2023 $224 · 2024 $624 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $127 |
| PFIZER INC. | 5 | $103 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| ABBVIE INC. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Ardelyx, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
Products named: CAPLYTA, Auvelity, NURTEC ODT, SHINGRIX, PAXLOVID, AIRSUPRA, BREZTRI, XIFAXAN.
Industry payments across NY — which companies pay providers there.
